ENLIVEN THERAPEUTICS, INC. Payments to Acquire Productive Assets
ENLIVEN THERAPEUTICS, INC. (ELVN) reported Payments to Acquire Productive Assets of $99.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2026-08-05
- ENLIVEN THERAPEUTICS, INC. payments to acquire productive assets for the quarter ending 2026-06-30 was $99.00K, a 28.78% decline year-over-year.
- ENLIVEN THERAPEUTICS, INC. payments to acquire productive assets for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- ENLIVEN THERAPEUTICS, INC. payments to acquire productive assets for the quarter ending 2025-12-31 was $0.00.
- ENLIVEN THERAPEUTICS, INC. payments to acquire productive assets for the quarter ending 2025-09-30 was -$1.00K, a 104.55% decline year-over-year.
- ENLIVEN THERAPEUTICS, INC. payments to acquire productive assets for fiscal 2025 was $158.00K, a 259.09% increase from fiscal 2024.
- ENLIVEN THERAPEUTICS, INC. payments to acquire productive assets for fiscal 2024 was $44.00K, a 70.47% decline from fiscal 2023.
- ENLIVEN THERAPEUTICS, INC. payments to acquire productive assets for fiscal 2023 was $149.00K, a 75.65% decline from fiscal 2022.
- ENLIVEN THERAPEUTICS, INC. payments to acquire productive assets for fiscal 2022 was $612.00K.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 3 month as first filed | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 6 month as first filed | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 9 month as first filed | Payments to Acquire Productive Assets 12 month | Payments to Acquire Productive Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $99.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $99.00K 10-Q · filed 2026-08-05 | $99.00K derived: sum of 3 quarters · filed 2026-08-05 | $98.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | -$1.00K derived: sum of 3 quarters · filed 2026-05-07 | $138.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$1.00K derived: sum of 2 quarters · filed 2026-03-03 | $138.00K derived: sum of 3 quarters · filed 2026-08-05 | $158.00K 10-K · filed 2026-03-03 | ||||
| 2025-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $138.00K derived: sum of 2 quarters · filed 2026-08-05 | $158.00K 10-Q · filed 2025-11-12 | $158.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $139.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $159.00K 10-Q · filed 2026-08-05 | $159.00K derived: sum of 3 quarters · filed 2026-08-05 | $181.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $20.00K 10-Q · filed 2026-05-07 | $20.00K derived: sum of 2 quarters · filed 2026-05-07 | $42.00K derived: sum of 3 quarters · filed 2026-05-07 | $44.00K derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $22.00K derived: sum of 2 quarters · filed 2026-03-03 | $24.00K derived: sum of 3 quarters · filed 2026-03-03 | $44.00K 10-K · filed 2026-03-03 | ||||
| 2024-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $24.00K derived: sum of 2 quarters · filed 2025-11-12 | $44.00K 10-Q · filed 2025-11-12 | $58.00K derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $22.00K 10-Q · filed 2025-08-13 | $36.00K derived: sum of 3 quarters · filed 2025-08-13 | $52.00K derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $20.00K 10-Q · filed 2025-05-14 | $34.00K derived: sum of 2 quarters · filed 2025-05-14 | $50.00K derived: sum of 3 quarters · filed 2025-05-14 | $138.00K derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $30.00K derived: sum of 2 quarters · filed 2025-03-13 | $118.00K derived: sum of 3 quarters · filed 2025-03-13 | $149.00K 10-K · filed 2025-03-13 | ||||
| 2023-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $104.00K derived: sum of 2 quarters · filed 2024-11-13 | $135.00K 10-Q · filed 2024-11-13 | $236.00K derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $119.00K 10-Q · filed 2024-08-13 | $220.00K derived: sum of 3 quarters · filed 2024-08-13 | $234.00K derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $31.00K 10-Q · filed 2024-05-14 | $132.00K derived: sum of 2 quarters · filed 2024-05-14 | $146.00K derived: sum of 3 quarters · filed 2024-05-14 | $449.00K derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $115.00K derived: sum of 2 quarters · filed 2024-03-14 | $418.00K derived: sum of 3 quarters · filed 2024-03-14 | $612.00K 10-K · filed 2024-03-14 | $363.00K 10-K · filed 2023-02-10 | |||
| 2022-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $317.00K derived: sum of 2 quarters · filed 2023-11-09 | $511.00K 10-Q · filed 2023-11-09 | $363.00K 10-Q · filed 2022-10-25 | $690.00K derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | $303.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $497.00K 10-Q · filed 2023-08-10 | $342.00K 10-Q · filed 2022-08-03 | $676.00K derived: sum of 3 quarters · filed 2023-08-10 | $676.00K derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | $194.00K 10-Q · filed 2023-05-11 | $135.00K 10-Q · filed 2022-05-06 | $373.00K derived: sum of 2 quarters · filed 2023-06-23 | $373.00K derived: sum of 3 quarters · filed 2023-06-23 | $373.00K derived: sum of 4 quarters · filed 2023-06-23 | |||
| 2021-12-31 | $179.00K derived: 8-K 12 month − 10-Q 9 month · filed 2023-06-23 | $179.00K derived: sum of 2 quarters · filed 2023-06-23 | $179.00K derived: sum of 3 quarters · filed 2023-06-23 | $191.00K 8-K · filed 2023-06-23 | $12.00K 10-K · filed 2022-03-15 | |||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | $0.00 derived: sum of 2 quarters · filed 2022-10-25 | $12.00K 10-Q · filed 2022-10-25 | $8.00K derived: sum of 4 quarters · filed 2022-10-25 | ||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $12.00K 10-Q · filed 2022-08-03 | $8.00K derived: sum of 3 quarters · filed 2022-08-03 | $8.00K derived: sum of 4 quarters · filed 2022-08-03 | ||||
| 2021-03-31 | $12.00K 10-Q · filed 2022-05-06 | $8.00K derived: sum of 2 quarters · filed 2022-05-06 | $8.00K derived: sum of 3 quarters · filed 2022-05-06 | $15.00K derived: sum of 4 quarters · filed 2022-05-06 | ||||
| 2020-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$4.00K derived: sum of 2 quarters · filed 2022-03-15 | $3.00K derived: sum of 3 quarters · filed 2022-03-15 | $18.00K 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $7.00K derived: sum of 2 quarters · filed 2021-11-09 | $22.00K 10-Q · filed 2021-11-09 | $22.00K derived: sum of 4 quarters · filed 2021-11-09 | ||||
| 2020-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $22.00K 10-Q · filed 2021-08-06 | $22.00K derived: sum of 3 quarters · filed 2021-08-06 | $81.00K derived: sum of 4 quarters · filed 2021-08-06 | ||||
| 2020-03-31 | $15.00K 10-Q · filed 2021-05-11 | $15.00K derived: sum of 2 quarters · filed 2021-05-11 | $74.00K derived: sum of 3 quarters · filed 2021-05-11 | |||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $59.00K derived: sum of 2 quarters · filed 2021-03-05 | $140.00K 10-K · filed 2021-03-05 | |||||
| 2019-09-30 | $59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $140.00K 10-Q · filed 2020-11-05 | ||||||
| 2019-06-30 | $81.00K 10-Q · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 |